Page last updated: 2024-08-24

xemilofiban and Recrudescence

xemilofiban has been researched along with Recrudescence in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kikuchi, S; Kondo, K; Nakashima, M; Nishiyama, H; Umemura, K	1
Alexander, J; Anders, R; Dreiling, R; Gong, J; Kleiman, J; Knudtson, M; O'Neill, WW; Roecker, EB; Serruys, P; Timmis, GC; van der Zwaan, C; van Es, GA	1

Trials

1 trial(s) available for xemilofiban and Recrudescence

Article	Year
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. The New England journal of medicine, 2000, May-04, Volume: 342, Issue:18 Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Benzamidines; Coronary Artery Bypass; Coronary Disease; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombocytopenia	2000

Article

Year

Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.

The New England journal of medicine, 2000, May-04, Volume: 342, Issue:18

Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Benzamidines; Coronary Artery Bypass; Coronary Disease; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombocytopenia

2000

Other Studies

1 other study(ies) available for xemilofiban and Recrudescence

Article	Year
Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery. Thrombosis and haemostasis, 1996, Volume: 76, Issue:5 Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Benzamidines; Cell Movement; Cells, Cultured; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Femoral Artery; Guinea Pigs; Male; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Photochemistry; Plasminogen Activators; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reactive Oxygen Species; Recombinant Proteins; Recurrence; Rose Bengal	1996

Article

Year

Inhibitory effect of a novel orally active GP IIb/IIIa inhibitor, SC-54684A on intimal thickening in the guinea pig femoral artery.

Thrombosis and haemostasis, 1996, Volume: 76, Issue:5

Topics: Angioplasty, Balloon, Coronary; Animals; Aspirin; Benzamidines; Cell Movement; Cells, Cultured; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Femoral Artery; Guinea Pigs; Male; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Photochemistry; Plasminogen Activators; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reactive Oxygen Species; Recombinant Proteins; Recurrence; Rose Bengal

1996